REQUEST A DEMO
Total
USD $0.00
Search more companies

Ciruplastia - Drs. Monroy I.P.S. S.A.S. (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Ciruplastia - Drs. Monroy I.P.S. S.A.S. Profile Updated: October 02, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Ciruplastia - Drs. Monroy I.P.S. S.A.S. is an enterprise based in Colombia. Its main office is in Bogota D.C.. The company operates in the Ambulatory Health Care Services sector. It was first established on April 29, 2024. The latest financial highlights indicate a net sales revenue increase of 418.15% in 2025. A growth of 162.47% was recorded in its total assets. Ciruplastia - Drs. Monroy I.P.S. S.A.S.’s net profit margin decreased by 9.92% in 2025.

Headquarters
Ak 15 No. 92 - 29 Of 802 P1
Bogota D.C.; Bogota D.C;

Contact Details: Purchase the Ciruplastia - Drs. Monroy I.P.S. S.A.S. report to view the information.

Basic Information
Registered Capital:
Purchase the Ciruplastia - Drs. Monroy I.P.S. S.A.S. report to view the information.
Financial Auditors:
Purchase the Ciruplastia - Drs. Monroy I.P.S. S.A.S. report to view the information.
Incorporation Date:
April 29, 2024
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Ciruplastia - Drs. Monroy I.P.S. S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
418.15%
Total Operating Revenue
418.15%
Operating Profit
137.69%
EBITDA
147.14%
Net Profit/Loss for the Period
-22.55%
Total Assets
162.47%
Total Equity
12.4%
Operating Profit Margin
-8.61%
Net Profit Margin
-9.92%
Return on Equity (ROE)
-10.54%
Quick Ratio
-0.95%
Cash Ratio
-0.65%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?